Raymond James & Associates Spdr Ser Tr Spdr S&P Pharmaceu Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Raymond James & Associates holds 7,602 shares of XPH stock, worth $305,448. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,602

Previous 7,229 5.16%

Holding current value

$305,448

Previous $287,000 17.42%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$39.24 - $45.31 $14,636 - $16,900	373 Added 5.16%	7,602 $337,000
Q2 2024 Jul 19, 2024	BUY	$39.09 - $42.64 $35,650 - $38,887	912 Added 14.44%	7,229 $287,000
Q1 2024 Apr 22, 2024	BUY	$41.38 - $45.49 $5,544 - $6,095	134 Added 2.17%	6,317 $272,000
Q4 2023 Jan 16, 2024	SELL	$35.2 - $41.92 $225,033 - $267,994	-6,393 Reduced 50.83%	6,183 $257,000
Q3 2023 Oct 24, 2023	BUY	$39.75 - $44.12 $113,804 - $126,315	2,863 Added 29.48%	12,576 $499,000
Q2 2023 Jul 25, 2023	BUY	$39.1 - $42.57 $93,605 - $101,912	2,394 Added 32.71%	9,713 $398,000
Q1 2023 Apr 14, 2023	BUY	$39.61 - $44.25 $11,170 - $12,478	282 Added 4.01%	7,319 $300,000
Q4 2022 Feb 08, 2023	BUY	$40.06 - $43.59 $60,891 - $66,256	1,520 Added 27.55%	7,037 $288,000
Q3 2022 Oct 25, 2022	BUY	$39.59 - $44.52 $218,418 - $245,616	5,517 New	5,517 $222,000
Q2 2022 Aug 12, 2022	SELL	$38.15 - $46.44 $287,116 - $349,507	-7,526 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$41.55 - $46.61 $97,559 - $109,440	-2,348 Reduced 23.78%	7,526 $341,000
Q4 2021 Feb 08, 2022	SELL	$43.72 - $52.45 $58,060 - $69,653	-1,328 Reduced 11.86%	9,874 $456,000
Q3 2021 Nov 02, 2021	BUY	$46.51 - $53.1 $17,394 - $19,859	374 Added 3.45%	11,202 $531,000
Q2 2021 Aug 11, 2021	SELL	$48.16 - $53.09 $9,487 - $10,458	-197 Reduced 1.79%	10,828 $561,000
Q1 2021 May 14, 2021	SELL	$49.44 - $56.01 $105,455 - $119,469	-2,133 Reduced 16.21%	11,025 $555,000
Q4 2020 Feb 12, 2021	SELL	$43.42 - $52.06 $221,398 - $265,453	-5,099 Reduced 27.93%	13,158 $685,000
Q3 2020 Nov 04, 2020	SELL	$42.46 - $45.34 $24,584 - $26,251	-579 Reduced 3.07%	18,257 $794,000
Q2 2020 Jul 28, 2020	BUY	$34.56 - $44.18 $650,972 - $832,174	18,836 New	18,836 $810,000
Q1 2020 Apr 21, 2020	SELL	$31.56 - $47.91 $1.21 Million - $1.84 Million	-38,470 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$34.65 - $46.53 $25,121 - $33,734	-725 Reduced 1.85%	38,470 $1.76 Million
Q3 2019 Nov 07, 2019	BUY	$35.59 - $37.64 $1.15 Million - $1.22 Million	32,449 Added 481.01%	39,195 $1.4 Million
Q2 2019 Aug 06, 2019	SELL	N/A	-41,020 Reduced 85.88%	6,746 $269,000
Q1 2019 May 06, 2019	SELL	N/A	-16,788 Reduced 26.01%	47,766 $1.99 Million
Q4 2018 Feb 11, 2019	SELL	N/A	-5,181 Reduced 7.43%	64,554 $2.36 Million
Q3 2018 Nov 14, 2018	BUY	N/A	2,293 Added 3.4%	69,735 $3.39 Million
Q2 2018 Aug 14, 2018	SELL	N/A	-520 Reduced 0.77%	67,442 $2.9 Million
Q1 2018 May 14, 2018	SELL	N/A	-23,947 Reduced 26.06%	67,962 $2.85 Million
Q4 2017 Feb 14, 2018	BUY	N/A	49,976 Added 119.18%	91,909 $4 Million
Q3 2017 Nov 13, 2017	SELL	N/A	-25,693 Reduced 37.99%	41,933 $1.78 Million
Q2 2017 Aug 14, 2017	BUY	N/A	67,626	67,626 $2.91 Million

Others Institutions Holding XPH

# of Institutions

Shares Held

2.9M

Call Options Held

13K

Put Options Held

26.1K

View Full List

About SPDR SER TR SPDR S&P PHARMACEU

Ticker XPH
Sector ETFs
Industry ETFs

More about XPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Spdr Ser Tr Spdr S&P Pharmaceu Transaction History